Skip to main content
. 2017 Sep 11;37(1):128–138. doi: 10.1038/onc.2017.316

Figure 7.

Figure 7

EGR1 mediates the expression of TGF-β1 induced by oncogenic KRAS. (a) Oncogenic KRAS upregulated TGF-β1 expression and this was inhibited by MEK inhibitor U0126. (b) KRAS-induced EGR1 expression. MEK inhibitor U0126 suppressed the induction. (c) Induction of TGFb1 by oncogenic KRAS relies on EGR1-binding site in promoter as shown by luciferase reporter assay. The value is presented as the mean±s.e.m. ** P<0.01, ***P<0.001.